Dako Launches Advanced Staining Platform at Global Pathology Congress
GLOSTRUP, DENMARK -- (Marketwire) -- 03/04/13 -- Dako, an Agilent
Technologies Company and worldwide provider of cancer diagnostics,
unveiled the newest addition to its IHC portfolio at the 2013 USCAP
congress in Baltimore, Md., today. As the exclusive Platinum Sponsor
of the congress, Dako used the opportunity to present its new
advanced staining solution to a global gathering of pathologists and
The solution, Dako Omnis, comprises hardware, software and reagents.
It automates both IHC and ISH processes, meaning entire patient cases
can be processed simultaneously. This allows pathologists to make
quicker, more informed diagnoses. Oncologists can in turn prescribe
relevant therapy with less anxiety-ridden waiting time for patients.
"This solution provides a breakthrough in addressing some of the
hitherto unmet needs in the anatomic pathology lab," said Dr. Pedro
L. Fernandez of the Hospital Clinic and University of Barcelona,
Spain. "Dako adopted a collaborative approach to bring this solution
to market and cooperated with a global panel of key independent
laboratory personnel. For over three years, we have been involved in
the design and development of this solution. Dako has really listened
and responded to the needs of the customer."
"Our customers tell us they are constantly expected to navigate
fluctuating slide numbers with fewer qualified staff and mounting
pressure to provide slides quickly in order to speed diagnosis," said
Lisa Miller, corporate vice president of Global Commercial Business,
"With continuous loading, batch loading and overnight run options all
available, Dako Omnis sets new standards for what customers can
expect from an automated platform in terms of flexibility, capacity,
efficiency and traceability of slides," she added.
Dako Omnis provides state-of-the-art software to bring lab control to
a new level. Now, key processes such as slide processing and
instrument maintenance can be traced to individual operators, greatly
increasing quality control.
As with all Dako's instruments, customers can use the Dako Link
software to connect all solutions and workstations to the
laboratory's own information system. This approach gives the lab
r even more control over the processing of each individual
slide that enters the lab.
Dako Omnis will be offered as part of Dako's current IHC portfolio,
which includes the Autostainer Link 48 instrument, which Dako will
continue to supply and support.
"Each pathology lab is different, and we believe with the addition of
Dako Omnis to our current IHC offering, Dako has an even greater
capability to bring the right solution to the right customer at the
right time," said Miller. "Dako has a reputation for bringing firsts
to market, with an unwavering passion for providing quality
solutions. This enables us to offer our customers efficiency, choice
and more time to ultimately provide better patient care. Advancing
pathology is at the heart of what we do, and our customers tell us
our new platform is an important addition."
About Dako - An Agilent Technologies Company
Dako, based in Denmark,
is a global leader in tissue-based cancer diagnostics. Hospital and
research laboratories worldwide use Dako's reagents, instruments,
software and expertise to make accurate diagnoses and determine the
most effective treatment for cancer patients. Dako, with 1,200
employees, operates in more than 100 countries. Dako became part of
Agilent Technologies on June 21, 2012. Information about Dako is
available at www.dako.com.
About Agilent Technologies
Agilent Technologies Inc. (NYSE: A) is
the world's premier measurement company and a technology leader in
chemical analysis, life sciences, diagnostics, electronics and
communications. The company's 20,500 employees serve customers in
more than 100 countries. Agilent had revenues of $6.9 billion in
fiscal 2012. Information about Agilent is available at
Director, Science Agenda
Dako Denmark A/S
+45 2933 6980
Press spacebar to pause and continue. Press esc to stop.